Date Field | Doc. No. | Description (Pages) |
---|
Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Main Document) (2) |
Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Appendix A, Proposed Patent Scheduling Order (ANDA)) (14) |
Jun 6, 2023 | 12 | Letter to The Honorable Gregory B. Williams from Francis DiGiovanni regarding Proposed Patent Scheduling Order (ANDA). (Attachments: # 1 Appendix A, Proposed Patent Scheduling Order (ANDA), # 2 Appendix B, Redline)(DiGiovanni, Francis) (Entered: 06/06/2023) (Appendix B, Redline) (16) |
Jan 24, 2023 | 11 | ANSWER to 8 Answer to Complaint, Counterclaim Supernus Pharmaceuticals, Inc.'s Answer to Defendant's Counterclaims by Supernus Pharmaceuticals, Inc..(DiGiovanni, Francis) (Entered: 01/24/2023) (30) |
Jan 6, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Neal Seth, Wesley Weeks, Corey Weinstein, and Kirby B. Drake - filed by Ajanta Pharma Limited. (Stamoulis, Stamatios) (Entered: 01/06/2023) (7) |
Jan 3, 2023 | 8 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Ajanta Pharma Limited.(Stamoulis, Stamatios) (Entered: 01/03/2023) (30) |
Jan 3, 2023 | 9 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ajanta Pharma Limited. (Stamoulis, Stamatios) (Entered: 01/03/2023) (3) |
Nov 16, 2022 | 7 | STIPULATION TO EXTEND TIME for Defendant to move, answer or otherwise respond to the Complaint to January 3, 2023 - filed by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 11/16/2022) (2) |
Nov 4, 2022 | 6 | MOTION for Pro Hac Vice Appearance of Attorney Edward H. Haug, Nicholas F. Giove, Jason A. Kanter, Camile Y. Turner, and Anna N. Lukacher - filed by Supernus Pharmaceuticals, Inc.. (DiGiovanni, Francis) (Entered: 11/04/2022) (7) |
Oct 28, 2022 | 1 | Complaint* (1) |
Oct 28, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 10/31/2022) (3) |
Oct 28, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/21/2022. Date of Expiration of Patent: 04/13/2027.Thirty Month Stay Deadline: 3/21/2025. (mpb) (Entered: 10/31/2022) (1) |
Oct 28, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (mpb) (Entered: 10/31/2022) (2) |
Oct 28, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Supernus Pharmaceuticals, Inc.. (mpb) (Entered: 10/31/2022) (2) |